Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)
China · Delayed Price · Currency is CNY 23.80
-0.03 (-0.13%)
At close: Oct 9, 2026
SHE:300937 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 4,471 | 4,454 | 4,395 | 4,430 | 3,969 | 3,401 |
Revenue Growth | 3.20% | 1.35% | -0.81% | 11.62% | 16.72% | 21.88% |
Gross Profit Gross Profit Growth | 425.87 | 459.48 | 382.22 | 357.85 | 306.05 | 181.48 |
Operating Income Operating Income Growth | 9.18 | 27.94 | 25.41 | 73.97 | 58.19 | 0.04 |
Net Income Net Income Growth | -13.13 | -12.85 | 13.2 | 59.53 | 42.02 | 6.4 |
Earnings Per Share EPS Growth | -0.14 | -0.13 | 0.17 | 0.62 | 0.44 | 0.07 |
EPS Growth | - | - | -72.58% | 40.91% | 528.57% | -90.67% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Wholesale - Terminal Pure Sales Pharmaceutical Wholesale - Terminal Pure Sales Growth | 2,424 | 2,264 | 2,363 | 2,372 | 2,111 |
Pharmaceutical Wholesale - Commercial Distribution Pharmaceutical Wholesale - Commercial Distribution Growth | 1,511 | 1,752 | 1,974 | 1,542 | 1,246 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 367.53 | 232.32 | 39.33 | 12.68 | 12.55 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 117.88 | 112.21 | 30.31 | 19.59 | 14.38 |
health products, technologies and services health products, technologies and services Growth | 33.06 | 34.68 | 23.54 | 23.65 | 16.23 |
Total Total Growth | 4,454 | 4,395 | 4,430 | 3,969 | 3,401 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 391.64 | 418.64 | 392.5 | 379.69 | 464.82 | 153.78 |
Total Debt Total Debt Growth | 291.68 | 334.74 | 388.85 | 329.63 | 243.62 | 129.8 |
Net Cash (Debt) Net Cash Growth | 99.96 | 83.89 | 3.65 | 50.06 | 221.21 | 23.98 |
Net Cash Growth | 440.32% | 2200.11% | -92.72% | -77.37% | 822.60% | -67.68% |
Net Cash Per Share Net Cash Per Share Growth | 1.04 | 0.88 | 0.05 | 0.52 | 2.32 | 0.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1.09 | -13.23 | 124.43 | -115.47 | 152.67 | -154.38 |
Capital Expenditures CapEx Growth | -8.92 | -7.57 | -32.41 | -35.33 | -18.32 | -31.43 |
Free Cash Flow Free Cash Flow Growth | -7.83 | -20.8 | 92.02 | -150.8 | 134.35 | -185.81 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 9.52% | 10.32% | 8.70% | 8.08% | 7.71% | 5.34% |
Operating Margin | 0.21% | 0.63% | 0.58% | 1.67% | 1.47% | 0.00% |
Pretax Margin | -0.09% | 0.16% | 0.27% | 1.58% | 1.13% | 0.24% |
Profit Margin | -0.29% | -0.29% | 0.30% | 1.34% | 1.06% | 0.19% |
FCF Margin | -0.18% | -0.47% | 2.09% | -3.40% | 3.38% | -5.46% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 0.220 | 0.200 |
Dividend Per Share Growth | -54.55% | 10.00% | - |
Dividend Yield | 0.40% | 0.71% | 0.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 181.33 | 50.54 | 65.71 | 680.87 |
P/FCF Ratio | - | - | 26.01 | - | 20.55 | - |
PS Ratio | 0.51 | 0.73 | 0.55 | 0.68 | 0.70 | 1.28 |